Women | | | | | | |
CT (15–39 years) | 2.7 (2.1 to 3.4) | 1.4 (0.7 to 2.1) | 6.4 (4.8 to 7.9)* | 3.2 (2.8–3.7) | 1.6 (1.4–1.8) | 13.0 (9.8–28.6) |
NG (15–39 years) | 1.6 (1.1 to 2.1) | 1.5 (0.7 to 2.2) | 1.9 (1.0 to 2.8)* | 1.9 (1.7–3.3) | 1.8 (1.6–3.0) | 2.3 (0.8–3.8) |
TV (15–49 years) | 24.3 (23.2 to 25.4) | – | 25.6 (23.1 to 28.1)* | 30.8 (27.6–34.9) | – | 41.9 (29.7–70.5) |
HSV-2 (15–29 years) | 41.9 (36.8 to 47.0) | 44.1 (42.4 to 45.8) | 46.8 (40.2 to 53.4) | 42.8 | 44.2 | 47.4 |
Serological syphilis (15–54 years) | 9.9 (9.2 to 10.7) | 11.3 (10.5 to 12.1) | 8.9 (8.2 to 9.6) | nar | nar | nar |
High titre syphilis (15–54 years) | 1.4 (1.1 to 1.7) | 0.7 (0.5 to 0.9) | 6.3 (5.8 to 6.9) | nar | nar | nar |
Men | | | | | | |
CT (15–39 years) | 2.4 (1.7 to 3.0) | 1.9 (0.9 to 2.9) | 1.0 (0.7 to 1.2) | 2.7 (2.4–3.1) | 2.2 (1.9–2.5) | 2.3 (1.9–2.8) |
NG (15–39 years) | 0.9 (0.5 to 1.4) | 0.8 (0.1 to 1.4) | 2.1 (1.6 to 2.5) | 1.1 | 0.9 | 2.8 |
HSV-2 (15–29 years) | 23.0 (18.4 to 27.6) | 20.2 (18.6 to 21.6) | 18.2 (12.8 to 23.6) | 21 | 16.8 | 13.3 |
Serological syphilis (15–54 years) | 9.6 (8.8 to 10.4) | 11.3 (10.5 to 12.3) | 7.3 (6.6 to 8.0) | nar | nar | nar |
High-titre syphilis (15–54 years) | 2.3 (1.9 to 2.7) | 1.2 (0.9 to 1.5) | 5.6 (5.0 to 6.2) | nar | nar | nar |